1-5 of 5
Susan M. Perkins
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2997: Epigenomic signatures of acquired platinum resistance in high grade serous ovarian cancer

Fang Fang, Horacio Cardenas, Guanglong Jiang, Susan M. Perkins, Chi Zhang, Harold Keer, Yunlong Liu, Daniela Matei, Kenneth Nephew
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 2997.
https://doi.org/10.1158/1538-7445.AM2018-2997
Published: 01 July 2018
View article titled, Abstract 2997: Epigenomic signatures of acquired platinum resistance in high grade serous ovarian cancer
Journal Articles

Genomic and Epigenomic Signatures in Ovarian Cancer Associated with Resensitization to Platinum Drugs

Fang Fang, Horacio Cardenas, Hao Huang, Guanglong Jiang, Susan M. Perkins, Chi Zhang, Harold N. Keer, Yunlong Liu, Kenneth P. Nephew, Daniela Matei
Journal: Cancer Research
Cancer Res (2018) 78 (3): 631–644.
https://doi.org/10.1158/0008-5472.CAN-17-1492
Published: 31 January 2018
View article titled, Genomic and Epigenomic Signatures in Ovarian Cancer Associated with Resensitization to Platinum Drugs
Open the PDF for Genomic and Epigenomic Signatures in Ovarian Cancer Associated with Resensitization to Platinum Drugs in another window
Includes: Supplementary data
Journal Articles

Abstract CT015: Results from a phase I/II study with the HDAC inhibitor entinostat in combination with high-dose interleukin-2 in renal cell carcinoma patients (CTEP#7870)

Roberto Pili, David I. Quinn, Hans J. Hammers, J. Paul Monk, Saby George, Tanya B. Dorff, Thomas Olencki, Li Shen, Dominick Lamonica, Alan Hutson, Adrienne Groman, Susan M. Perkins, Richard Piekarz, Michael Carducci
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): CT015.
https://doi.org/10.1158/1538-7445.AM2016-CT015
Published: 15 July 2016
View article titled, Abstract CT015: Results from a phase I/II study with the HDAC inhibitor entinostat in combination with high-dose interleukin-2 in renal cell carcinoma patients (CTEP#7870)
Journal Articles

Chemotherapeutic Agents Subvert Tumor Immunity by Generating Agonists of Platelet-Activating Factor

Ravi P. Sahu, Jesus A. Ocana, Kathleen A. Harrison, Matheus Ferracini, Christopher E. Touloukian, Mohammed Al-Hassani, Louis Sun, Mathew Loesch, Robert C. Murphy, Sandra K. Althouse, Susan M. Perkins, Paul J. Speicher, Douglas S. Tyler, Raymond L. Konger, Jeffrey B. Travers
Journal: Cancer Research
Cancer Res (2014) 74 (23): 7069–7078.
https://doi.org/10.1158/0008-5472.CAN-14-2043
Published: 30 November 2014
View article titled, Chemotherapeutic Agents Subvert Tumor Immunity by Generating Agonists of Platelet-Activating Factor
Open the PDF for Chemotherapeutic Agents Subvert Tumor Immunity by Generating Agonists of Platelet-Activating Factor in another window
Includes: Supplementary data
Journal Articles

Abstract 1817: A computer-tailored intervention increases patient-provider discussion and appointment making for colorectal cancer screening

Connie J. Krier, Celette Sugg Skinner, Victoria L. Champion, Jeffrey Springston, Susan M. Perkins, Yan Tong, Netsanet Gebregziabher, Thomas F. Imperiale, Tawana Brady-Watts, Laura J. Myers, Susan M. Rawl
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 1817.
https://doi.org/10.1158/1538-7445.AM2011-1817
Published: 15 April 2011
View article titled, Abstract 1817: A computer-tailored intervention increases patient-provider discussion and appointment making for colorectal cancer screening